BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 16481920)

  • 41. Imaging with ultrasound contrast agents: current status and future.
    Chong WK; Papadopoulou V; Dayton PA
    Abdom Radiol (NY); 2018 Apr; 43(4):762-772. PubMed ID: 29508011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic applications of lipid-coated microbubbles.
    Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
    Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques.
    Zhang Q; Wang Z; Ran H; Fu X; Li X; Zheng Y; Peng M; Chen M; Schutt CE
    Acad Radiol; 2006 Mar; 13(3):363-7. PubMed ID: 16488849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel dual-targeted ultrasound contrast agent provides improvement of gene delivery efficiency in vitro.
    Xu J; Zeng X; Liu Y; Luo H; Wei Z; Liu H; Zhou Y; Zheng H; Zhou J; Tan G; Yan F
    Tumour Biol; 2016 Jul; 37(7):8609-19. PubMed ID: 26733178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasound contrast agents: an overview.
    Cosgrove D
    Eur J Radiol; 2006 Dec; 60(3):324-30. PubMed ID: 16938418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.
    Couture O; Dransart E; Dehay S; Nemati F; Decaudin D; Johannes L; Tanter M
    Mol Imaging; 2011 Apr; 10(2):135-43. PubMed ID: 21439258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular imaging of cardiovascular disease using ultrasound.
    Villanueva FS
    J Nucl Cardiol; 2008; 15(4):576-86. PubMed ID: 18674725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications.
    Upadhyay A; Dalvi SV
    Ultrasound Med Biol; 2019 Feb; 45(2):301-343. PubMed ID: 30527395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasound-driven microbubble oscillation and translation within small phantom vessels.
    Zheng H; Dayton PA; Caskey C; Zhao S; Qin S; Ferrara KW
    Ultrasound Med Biol; 2007 Dec; 33(12):1978-87. PubMed ID: 17900793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular drug delivery with ultrasound and microbubbles.
    Unger E; Porter T; Lindner J; Grayburn P
    Adv Drug Deliv Rev; 2014 Jun; 72():110-26. PubMed ID: 24524934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical applications of contrast-enhanced ultrasound].
    Dai Q; Jiang YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):1-4. PubMed ID: 18361043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury.
    Chen G; Yang L; Zhong L; Kutty S; Wang Y; Cui K; Xiu J; Cao S; Huang Q; Liao W; Liao Y; Wu J; Zhang W; Bin J
    Sci Rep; 2016 Jul; 6():30643. PubMed ID: 27469291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preparation of polyelectrolyte multilayer film-coated microbubble ultrasound contrast agent].
    Xing ZW; Ke HT; Liu SQ; Dai ZF; Wang JR; Liu JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):10-4. PubMed ID: 18361045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal retention of lipid microbubbles: a potential mechanism for flank discomfort during ultrasound contrast administration.
    Liu YN; Khangura J; Xie A; Belcik JT; Qi Y; Davidson BP; Zhao Y; Kim S; Inaba Y; Lindner JR
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1474-81. PubMed ID: 24035699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery.
    Escoffre JM; Mannaris C; Geers B; Novell A; Lentacker I; Averkiou M; Bouakaz A
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):78-87. PubMed ID: 23287915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WE-C-218-01: Ultrasound Contrast Agents.
    Streeter JE; Dayton PA
    Med Phys; 2012 Jun; 39(6Part27):3953. PubMed ID: 28520019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical principles of microbubbles for ultrasound imaging and therapy.
    Stride E
    Cerebrovasc Dis; 2009; 27 Suppl 2():1-13. PubMed ID: 19372656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbubbles as ultrasound triggered drug carriers.
    Tinkov S; Bekeredjian R; Winter G; Coester C
    J Pharm Sci; 2009 Jun; 98(6):1935-61. PubMed ID: 18979536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.
    Weller GE; Villanueva FS; Tom EM; Wagner WR
    Biotechnol Bioeng; 2005 Dec; 92(6):780-8. PubMed ID: 16121392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.